ISRG lows -2.6% and MDT -0.5% after earlier JNJ announced the FDA authorization for its Ottava Surgical Robot, marking its entry into the U.
ISRG lows -2.6% and MDT -0.5% after earlier JNJ announced the FDA authorization for its Ottava Surgical Robot, marking its entry into the U.S. robotic soft-tissue Surgery market
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.